Society guideline links: Myelodysplastic syndromes

Introduction — This topic includes links to society and government-sponsored guidelines from selected countries and regions around the world. We will update these links periodically; newer versions of some guidelines may be available on each society's website. Some societies may require users to log in to access their guidelines.

The recommendations in the following guidelines may vary from those that appear in UpToDate topic reviews. Readers who are looking for UpToDate topic reviews should use the UpToDate search box to find the relevant content.

Links to related guidelines are provided separately. (See "Society guideline links: Bone marrow failure syndromes".)

International

●International/European LeukemiaNet (ELN) Working Group for Flow Cytometry in MDS (IMDSFlow): Revisiting guidelines for integration of flow cytometry results in the WHO classification of myelodysplastic syndromes (2014)

United States

●American Society of Transplantation and Cellular Therapy (ASTCT): Guidelines on hematopoietic cell transplantation in the treatment of pediatric acute myelogenous leukemia and myelodysplastic syndromes (2022)

Europe

●European Society for Medical Oncology (ESMO): Myelodysplastic syndromes – Clinical practice guidelines for diagnosis, treatment and follow-up (2020)

●European Conference on Infections in Leukaemia (ECIL): European guidelines for primary antifungal prophylaxis in adult haematology patients – Summary of the updated recommendations (2018)

●International/European LeukemiaNet (ELN) Working Group for Flow Cytometry in MDS (IMDSFlow): Revisiting guidelines for integration of flow cytometry results in the WHO classification of myelodysplastic syndromes (2014)

●ELN: Recommendations for the diagnosis and treatment of primary myelodysplastic syndromes in adults (2013)

United Kingdom

●British Society for Haematology (BSH): Good practice paper on the use of genetic tests to diagnose and manage patients with myeloproliferative and myeloproliferative/myelodysplastic neoplasms, and related disorders (2021)

●BSH: Guidelines for the management of adult myelodysplastic syndromes (2021)